YOSPRALA (Aralez Pharmaceuticals Us Inc.)
Welcome to the PulseAid listing for the YOSPRALA drug offered from Aralez Pharmaceuticals Us Inc.. This Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Aralez Pharmaceuticals Us Inc. |
| NON-PROPRIETARY NAME: | Aspirin and Omeprazole |
| SUBSTANCE NAME: | ASPIRIN; OMEPRAZOLE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2016-09-14 |
| END MARKETING DATE: | 0000-00-00 |
YOSPRALA HUMAN PRESCRIPTION DRUG Details:
| Item Description | YOSPRALA from Aralez Pharmaceuticals Us Inc. |
| LABELER NAME: | Aralez Pharmaceuticals Us Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 81; 40(mg/1; mg/1) |
| START MARKETING DATE: | 2016-09-14 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 70347-081_40970d4a-a768-426a-8e8f-5f9b602acc52 |
| PRODUCT NDC: | 70347-081 |
| APPLICATION NUMBER: | NDA205103 |
Other ASPIRIN; OMEPRAZOLE Pharmaceutical Manufacturers / Labelers:
